Pfizer Inc.

Pharmaceutical industry

Judicial Panel on Multidistrict Litigation Transfers Zantac Products Liability Litigation to Southern District of Florida

The Judicial Panel on Multidistrict Litigation has transferred the Zantac (Ranitidine) Products Liability Litigation to the Southern District of Florida, with the support of the defendants, who include Sanofi-Aventis U.S. LLC, Boehringer Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline LLC, and others. The Panel held that the action involves common questions of

Vaccines

Elucidating the Antigen-Specific Cellular Response to mRNA-Based COVID-19 Vaccines

Researchers have made significant strides in understanding the antigen-specific cellular response to mRNA-based COVID-19 vaccines, utilizing single-cell profiling technologies and machine learning analyses to identify and characterize T cell, B cell, and antibody responses to the Pfizer-BioNTech BNT162b2 vaccine. The study sheds light on the challenges faced in understanding antigen-specific